|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/57 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61K 31/4365 | (2006.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/60 | (2006.01) | ||
| A61K 31/616 | (2006.01) | ||
| A61K 31/727 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| C07K 16/36 | (2006.01) | ||
| A61P 3/00 | (2006.01) | ||
| A61P 7/02 | (2006.01) | ||
| A61P 7/10 | (2006.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 9/10 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 21/00 | (2006.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) |
| (11) | Number of the document | 3013366 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14739078.5 |
| Date of filing the European patent application | 2014-06-27 | |
| (97) | Date of publication of the European application | 2016-05-04 |
| (45) | Date of publication and mention of the grant of the patent | 2021-08-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2014/063691 |
| Date | 2014-06-27 |
| (87) | Number | WO 2014/207199 |
| Date | 2014-12-31 |
| (30) | Number | Date | Country code |
| 201361840662 P | 2013-06-28 | US | |
| 13176605 | 2013-07-16 | EP |
| (72) |
NOLTE, Marc , DE
PRAGST, Ingo , DE
|
| (73) |
CSL Behring GmbH ,
Emil-von-Behring-Strasse 76, 35041 Marburg,
DE
|
| (54) | COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C1-INHIBITOR |
| COMBINATION THERAPY USING A FACTOR XII INHIBITOR AND A C1-INHIBITOR |